Sputnik Light, the single-dose COVID vaccine, gets DCGI nod for phase 3 trials in India

The nod comes after a recent study published in the medical journal The Lancet said that Sputnik Light showed 78.6 to 83.7 per cent efficacy against COVID-19, significantly higher than most two-shot vaccines.  

source https://zeenews.india.com/india/sputnik-light-the-single-dose-covid-vaccine-gets-dcgi-nod-for-phase-3-trials-in-india-2394105.html